Associate neurologist, Brigham and Women's Hospital; professor of neurology, Harvard Medical School
Exploiting Anti-CD3 Antibodies, Relevant Biomarkers in Progressive MS: Tanuja Chitnis, MD
The associate neurologist at Brigham and Women’s Hospital provided insight on the current state of promising targets in progressive MS and why anti-CD3 therapy might be a new consideration for future trials. [WATCH TIME: 2 minutes]
The Potential of Targeting Anti-CD3 in Progressive Multiple Sclerosis: Tanuja Chitnis, MD
The associate neurologist at Brigham and Women’s Hospital provided background on a new case study of a patient with progressive MS who showed positive outcomes using foralumab, an anti-CD3 targeting agent. [WATCH TIME: 3 minutes]
The Future of Pediatric Multiple Sclerosis
Tanuja Chitnis, MD and Lauren B. Krupp, MD give insight into the future of pediatric multiple sclerosis by discussing unmet needs and advice for community neurologists.
Drugs and Biomarkers in Development for Pediatric MS
Expert neurologists discuss drugs in development for pediatric multiple sclerosis and consider the potential for biomarkers to monitor treatment response or new disease activity in the future.
Defining Treatment Failure in Pediatric MS
Lauren B. Krupp, MD considers how treatment failure in pediatric multiple sclerosis may be defined as disease relapse, new or enlarging legions, inability to tolerate treatment, or lack of adherence.
Disease-Modifying Therapy in Relapsing-Remitting MS
Leaders in neurology provide insight into first-line disease-modifying therapies for relapsing-remitting multiple sclerosis, such as interferon or glatiramer acetate, and glucocorticoids for acute events.
Treatment Goals and Response Monitoring in Pediatric MS
Tanuja Chitnis, MD reviews the 2018 AAN guidelines on disease-modifying therapies and discusses goals of therapy when selecting first-line treatments and monitoring response in pediatric multiple sclerosis.
Emotional, Social, and Cognitive Challenges in Pediatric MS
Experts in multiple sclerosis discuss the importance of a multidisciplinary approach for pediatric patients and emphasize the role of social workers, psychologists, and support groups for patients and families.
Diagnostic Testing for Pediatric Multiple Sclerosis
Expert neurologist Lauren B. Krupp, MD provides insight into the use of diagnostic tools for pediatric multiple sclerosis such as MRI imaging, laboratory blood tests, and lumbar punctures.
Differential Diagnosis of Pediatric Multiple Sclerosis
Key opinion leaders in the management of MS comment on the current diagnostic criteria and discuss the importance of ruling out other common mimics in pediatric patients.
Clinical Presentation of Pediatric Multiple Sclerosis
Lauren B. Krupp, MD provides insight into the signs and symptoms of multiple sclerosis and emphasizes differences in clinical presentation between adult and pediatric patients.
Safety and Efficacy of Fingolimod for Pediatric MS
Thought leaders in neurology discuss the results of the phase 3 PARADIGMS trial as well as the safety and efficacy of fingolimod for use in pediatric patients with multiple sclerosis.
An Overview of Etiology and Prevalence of Pediatric MS
Tanuja Chitnis, MD provides an overview of genetic, environmental, and hormonal risk factors for pediatric multiple sclerosis and discusses its prevalence based on age, sex, and geographic location.
Tanuja Chitnis, MD: Consequences of Incomplete Recovery in MS
The director of the Partners Pediatric MS Center at Massachusetts General Hospital for Children provided insight on the consequences of incomplete relapse recovery in multiple sclerosis.
Tanuja Chitnis, MD: Nfl Levels In Long-Term MS Outcomes
The professor of neurology at Harvard Medical School spoke about the long-term correlations between neurofilament light chain and MS outcomes.
Tanuja Chitnis, MD: Diagnosing Pediatric MS
The professor of neurology at Harvard Medical School shared her methods for diagnosing pediatric MS and about the importance of managing the disease in a larger sense.
Tanuja Chitnis, MD: Differentiating Pediatric MS From Other Demyelinating Disorders
The professor of neurology at Harvard Medical School provided some insight into her experience with treating pediatric patients with MS.
2 Clarke Drive Cranbury, NJ 08512